Press Releases from DelveInsight (45 total)
Chronic Myeloid Leukemia Pipeline: Driving Innovation with 25+ Pioneering Compan …
The chronic myelocytic leukemia market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Aprea Therapeutics, Treadwell Therapeutics, Prelude Therapeutics, and Onconova Therapeutics. These industry pioneers are transforming treatment strategies and redefining the future of Chronic Myelocytic Leukemia care, bringing new hope to patients worldwide.
DelveInsight's "Chronic Myelocytic Leukemia Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Chronic…
Chronic Heart Failure Pipeline: Advancing Innovation with 25+ Pioneers Shaping t …
The chronic heart failure market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Tasly Pharmaceuticals, Berlin Cures, CardioCell, Help Therapeutics, and Eli Lilly and Company. These industry pioneers are transforming treatment strategies and redefining the future of Chronic Heart Failure care, bringing new hope to patients worldwide.
DelveInsight's "Chronic Heart Failure Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects…
Beta-Thalassemia Pipeline: Advancing Innovation with 22+ Trailblazers Developing …
The beta-thalassemia market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Disc Medicine, Novartis, Merck, and Bristol Myers Squibb. These industry pioneers are transforming treatment strategies and redefining the future of Beta-thalassemia care, bringing new hope to patients worldwide.
DelveInsight's "Beta-thalassemia Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Beta-thalassemia market. The report covers disease insights, treatment…
Attention Deficit Hyperactivity Disorder Pipeline: Advancing Innovation with 20+ …
The attention deficit hyperactivity disorder market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as 3Z Pharmaceuticals, Shire, Takeda, and New River Pharmaceuticals. These industry pioneers are transforming treatment strategies and redefining the future of Attention Deficit Hyperactivity Disorder care, bringing new hope to patients worldwide.
DelveInsight's "Attention Deficit Hyperactivity Disorder Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in…
Amyotrophic Lateral Sclerosis Pipeline: Advancing the Future with 50+ Innovators …
The amyotrophic lateral sclerosis market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Denali Therapeutics, AbbVie, Calico Life Sciences, and Clene Nanomedicine Biosciences. These industry pioneers are transforming treatment strategies and redefining the future of Amyotrophic Lateral Sclerosis care, bringing new hope to patients worldwide.
DelveInsight's "Amyotrophic Lateral Sclerosis Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the…
Thrombocytopenia Pipeline: Transforming Treatment with 25+ Pioneers Driving Brea …
The thrombocytopenia market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Novartis Pharmaceuticals, Pfizer, HUTCHMED, Genosco, and UCB. These industry pioneers are transforming treatment strategies and redefining the future of Thrombocytopenia care, bringing new hope to patients worldwide.
DelveInsight's "Thrombocytopenia Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Thrombocytopenia market. The report covers disease insights, treatment guidelines, and…
Pancreatic Ductal Adenocarcinoma Pipeline: Shaping the Future with 80+ Innovator …
The pancreatic ductal adenocarcinoma market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Eucure Biopharma, Panbela Therapeutics, and Jeil Pharmaceutical. These industry pioneers are transforming treatment strategies and redefining the future of Pancreatic Ductal Adenocarcinoma care, bringing new hope to patients worldwide.
DelveInsight's "Pancreatic Ductal Adenocarcinoma Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Pancreatic Ductal Adenocarcinoma market.…
Chronic Urticaria Pipeline: Unleashing Hope with 20+ Innovators like UCB Biophar …
The chronic urticaria or hives market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Novartis, Synermore Biologics, Teva Pharmaceuticals, Regeneron Pharmaceuticals, Celltrion, and United BioPharma. These industry pioneers are transforming treatment strategies and redefining the future of Chronic Urticaria or Hives care, bringing new hope to patients worldwide.
DelveInsight's 'Chronic Urticaria Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Chronic Urticaria…
Ischemia Reperfusion Injury Pipeline: Pioneering the Future with 10+ Innovators …
The ischemia-reperfusion injury market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Calluna Pharma and CalciMedica. These industry pioneers are transforming treatment strategies and redefining the future of Ischemia-Reperfusion Injury care, bringing new hope to patients worldwide.
DelveInsight's 'Ischemia-Reperfusion Injury Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Ischemia-Reperfusion Injury therapies in various stages of clinical development. Major pharmaceutical companies are…
Ischemic Stroke Pipeline: Pioneering the Future with 50+ Innovators Driving Brea …
The Ischemic Stroke market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as NuvOx Pharma, Healios, Acticor Biotech, and DiaMedica Therapeutics. These industry pioneers are transforming treatment strategies and redefining the future of Ischemic Stroke care, bringing new hope to patients worldwide.
DelveInsight's "Ischemic Stroke Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Ischemic Stroke market. The report covers…
Malignant Mesothelioma Clinical Pipeline | 20+ Companies, Including Epizyme, Ys …
The Malignant Mesothelioma market is rapidly advancing and is fueled by groundbreaking research and innovative therapies from companies such as Epizyme, Ys Therapeutics, Novartis, Bayer, RS Oncology, and Polaris Pharmaceuticals. These industry pioneers are transforming treatment strategies and redefining the future of Malignant Mesothelioma care, bringing new hope to patients worldwide.
DelveInsight's 'Malignant Mesothelioma Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Malignant Mesothelioma therapies in various stages of…
Hyperkalemia Clinical Pipeline | Eli Lilly, Novo Nordisk, Sanofi, Ardelyx, and O …
The hyperkalemia market is rapidly advancing and fueled by groundbreaking research and innovative therapies from companies such as Eli Lilly, Novo Nordisk, Sanofi, and Ardelyx. These industry pioneers are transforming treatment strategies and redefining the future of Hyperkalemia care, bringing new hope to patients worldwide.
DelveInsight's "Hyperkalemia Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Hyperkalemia market. The report covers disease insights, treatment guidelines, and…
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generatio …
The Motor Neuron Disease market is evolving rapidly, driven by cutting-edge research and innovative treatment approaches. Leading pharmaceutical companies like GeneCradle Therapeutics, Verge Genomics, QurAlis Corporation, and Zydus Lifesciences are at the forefront of revolutionizing MND care, introducing novel therapies that offer new hope to patients worldwide. As these breakthrough treatments progress through clinical pipelines, they hold the potential to reshape the future of MND management.
DelveInsight's 'Motor Neuron Disease Pipeline…
Tau Inhibitors Clinical Pipeline | 20+ Companies Advancing the Future of Treatme …
The Tau Inhibitors market is rapidly advancing, driven by breakthrough research and innovative therapies from leaders like TauRx Therapeutics, Prothena, and UCB Biopharma. These pioneers are reshaping treatment strategies, bringing next-generation therapies closer to reality, and offering new hope for patients worldwide.
DelveInsight's 'Tau Inhibitors Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Tau Inhibitors therapies in various stages of clinical development. Major pharmaceutical companies are working to advance…
Complement Inhibitors Clinical Pipeline | Over 50 Companies Driving the Future o …
The Complement Inhibitors market is advancing rapidly, driven by groundbreaking research and innovative therapies from leaders like NovelMed Therapeutics, Arrowhead Pharmaceuticals, and BioCryst Pharmaceuticals. These pioneers are redefining treatment approaches and bringing new hope to patients worldwide.
DelveInsight's 'Complement Inhibitors Pipeline Insight 2025' report provides comprehensive global coverage of pipeline Complement Inhibitors therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future…
Renal Cancer Clinical Pipeline | 75+ Companies, Including Genentech, AstraZeneca …
The Renal Cancer market is evolving with cutting-edge research and new therapeutic advancements.
DelveInsight's 'Renal Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Renal Cancer therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Renal Cancer pipeline domain.
For Renal Cancer emerging drugs, the Renal Cancer pipeline analysis report provides a 360° view of the…
Advanced Kidney Cancer Clinical Pipeline | 50+ Companies Transforming the Future …
The Advanced Kidney Cancer market is rapidly evolving with cutting-edge research and breakthrough therapies, driven by leading companies like Janux Therapeutics, Infinity Pharmaceuticals, Merck Sharp & Dohme, and Xencor. These innovators are revolutionizing treatment approaches and shaping the future of Advanced Kidney Cancer care, offering new hope for patients worldwide.
DelveInsight's 'Advanced Kidney Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Advanced Kidney Cancer therapies in various stages…
Squamous Cell Carcinoma Clinical Pipeline | 75+ Companies Advancing the Future o …
The Squamous Cell Carcinoma market is rapidly evolving with cutting-edge research and breakthrough therapies driven by leading companies like AstraZeneca, VCN Biosciences, Moderna Therapeutics, Exelixis, and MacroGenics. These innovators are revolutionizing treatment approaches and shaping the future of Squamous Cell Carcinoma care, offering new hope for patients worldwide.
DelveInsight's 'Squamous Cell Carcinoma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Squamous Cell Carcinoma therapies in various stages of clinical…
Complicated Urinary Tract Infections Clinical Pipeline, 12+ Companies Driving th …
The market for Complicated Urinary Tract Infections is rapidly evolving, driven by groundbreaking research and innovative therapeutic advancements.
DelveInsight's 'Complicated Urinary Tract Infections Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Complicated Urinary Tract Infections therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Complicated Urinary Tract Infections pipeline domain.
For Complicated Urinary Tract Infections emerging…
Ulcerative Colitis Clinical Pipeline | 70+ Companies Pioneering the Next Breakth …
The ulcerative colitis market is undergoing a transformative shift, driven by cutting-edge research and innovative therapies.
DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Ulcerative Colitis therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Ulcerative Colitis pipeline domain.
For Ulcerative Colitis emerging drugs, the Ulcerative Colitis pipeline analysis report provides a…
Psoriatic Arthritis Clinical Pipeline | 20+ Companies Driving the Next Wave of I …
The Psoriatic Arthritis market is advancing rapidly, driven by groundbreaking research and innovative therapies.
DelveInsight's 'Psoriatic Arthritis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline Psoriatic Arthritis therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Psoriatic Arthritis pipeline domain.
For Psoriatic Arthritis emerging drugs, the Psoriatic Arthritis pipeline analysis report provides a 360° view of…
AL Amyloidosis Clinical Pipeline | 10+ Companies Advancing the Next Breakthrough …
The AL Amyloidosis market is evolving with cutting-edge research and new therapeutic advancements.
DelveInsight's 'AL Amyloidosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline AL Amyloidosis therapies in various stages of clinical development. Major pharmaceutical companies are working to advance the pipeline space and future growth potential of the AL Amyloidosis pipeline domain.
For AL Amyloidosis emerging drugs, the AL Amyloidosis pipeline analysis report provides a 360° view of the…
Follicular Lymphoma Clinical and Non-Clinical Studies, Key Companies, Therapeuti …
Follicular Lymphoma Pipeline constitutes 50+ key companies continuously working towards developing 55+ Follicular Lymphoma treatment therapies, analyzes DelveInsight.
Follicular Lymphoma Overview:
Follicular lymphoma (FL) is an indolent B-cell non-Hodgkin lymphoma (NHL), accounting for 20-30% of all NHL cases. While not typically curable, FL is often managed as a chronic condition, with patients living for many years post-diagnosis. FL originates from germinal center B-cells and is characterized by abnormal proliferation of malignant B-cells,…
CAR-T Cell Therapy Competitive Landscape 2024 (Updated)
DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the CAR-T Cell Therapy Report
• DelveInsight's CAR-T Cell Therapy report depicts a robust space…
Anterior Uveitis Treatment Market Size Report 2032 | DelveInsight
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To know in detail about the Anterior Uveitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Anterior Uveitis Market Forecast-- https://www.delveinsight.com/sample-request/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Some of the…
Antiphospholipid Syndrome Treatment Market Size 2032 | Genentech Inc, Bayer, Lum …
Antiphospholipid Syndrome market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
Antiphospholipid Syndrome Market Report gives readers a thorough assessment of key market drivers, restraints, prospects, opportunities, restraints, current trends, and technological and industrial breakthroughs that will influence market growth. The…
Atopic Dermatitis Market to grow significantly by 2032 | Sanofi, Regeneron Pharm …
(Delhi, India) To strategically aid companies developing drugs for Atopic Dermatitis, DelveInsight launched the report "Atopic Dermatitis Market" This comprehensive report delves into epidemiology-based market analysis, providing a roadmap for success in the dynamic landscape of the Atopic Dermatitis market.
DelveInsight's report titled "Atopic Dermatitis Market Insight, Epidemiology, and Market Forecast Forecast-2032" provides a comprehensive analysis of the historical and projected epidemiology of Atopic Dermatitis. Additionally, the report highlights trends…
Behçet's Disease Pipeline Outlook Report 2024 | Latest Drug Approvals, FDA, Cli …
DelveInsight's, "Behçet's Disease Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Behçet's Disease pipeline landscape. It covers Behçet's Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers Behçet's Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Behçet's Disease Pipeline Report
•…
C-MET Non-Small Cell Lung Cancer Pipeline Outlook Report 2024 | Latest Drugs App …
DelveInsight's, "C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the C-MET Non-Small Cell Lung Cancer pipeline landscape. It covers the C-MET Non-Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the C-MET Non-Small Cell Lung Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type.…
Dry Age-Related Macular Degeneration Pipeline Outlook, FDA Approvals, Emerging D …
DelveInsight's, "Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Dry…
Allergic Rhinitis APAC Market Poised for Phenomenal Expansion Across APAC Region …
"DelveInsight's "Allergic Rhinitis- Patient Pool Analysis, Market Size and Market Forecast APAC, 2034" report comprises of detailed understanding of the Allergic Rhinitis, historical and forecasted patient burden, treatment addressable patient population, as well as key differences in market trends in the APAC region (India, China, South Korea, Taiwan, and Australia) when compared with established markets.
The APAC Allergic Rhinitis market report provides current treatment pattern analysis, potential upcoming players, market share…
Severe Asthma Market Forecast 2034: FDA, EMA, PDMA Approvals, Clinical Trials, E …
DelveInsight's report titled "Severe Asthma Market Insights, Epidemiology, and Market Forecast - 2034" comprehensively analyzes Severe Asthma. The report provides a comprehensive analysis of historical and projected epidemiological data, covering Total Diagnosed Prevalent cases of Asthma, Severity-specific Diagnosed Prevalent cases of Asthma, and Type-specific Diagnosed Prevalent cases of Severe Asthma.
Key Takeaways from the Severe Asthma Market Forecast Report
• The increase in Severe Asthma Market Size is a direct consequence of the…
Triple Negative Breast Cancer Pipeline, Clinical Trials, FDA Approvals, Research …
DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Triple Negative Breast Cancer Companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the Triple Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Triple Negative Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights…
Multiple Myeloma Pipeline, FDA Approvals, Clinical Trials Developments, and Comp …
DelveInsight's, "Multiple Myeloma Pipeline Insights" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Myeloma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Postherpetic Neuralgia Market Size in 7MM is expected to witness a major change …
"The Postherpetic Neuralgia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Postherpetic Neuralgia pipeline products will significantly revolutionize the Postherpetic Neuralgia market dynamics"
The Postherpetic Neuralgia market report provides current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted 7MM Postherpetic Neuralgia market size from 2019 to 2032. The report also covers…
Acute Pain Pipeline, Clinical and Non-Clinical Stages Products, and FDA Approval …
DelveInsight's, "Acute Pain Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Acute Pain pipeline landscape. It covers the Acute Pain pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acute Pain pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the…
Cystic Fibrosis Pipeline, Clinical Trials Assessment, NDA Approvals, Emerging Dr …
DelveInsight's, "Cystic Fibrosis Pipeline Insight 2023" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including Cystic Fibrosis clinical trials and nonclinical stage products. It also covers the Cystic Fibrosis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
For…
Metastatic Pancreatic Cancer Pipeline and Clinical Trials Pipeline Analysis 2023 …
DelveInsight's, "Metastatic Pancreatic Cancer Pipeline Insight 2023" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Metastatic Pancreatic Cancer pipeline landscape. It covers the pipeline drug profiles, including Metastatic Pancreatic Cancer clinical trials and nonclinical stage products. It also covers the Metastatic Pancreatic Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.…
Metastatic Renal Cell Carcinoma Marketed and Emerging Pipeline Drugs Assessment …
As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 50+ pipeline drugs in the Metastatic Renal Cell Carcinoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Metastatic Renal Cell Carcinoma Pipeline Insight, 2023" report by DelveInsight…
CRISPR therapies Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Dr …
CRISPR therapies pipeline constitutes 25+ key companies continuously working towards developing 30+ CRISPR therapies treatment therapies, analyzes DelveInsight
CRISPR-Cas is an adaptive immune system existing in most bacteria and archaea, preventing them from being infected by phages, viruses and other foreign genetic elements. It is composed of CRISPR repeat-spacer arrays, which can be further transcribed into CRISPR RNA (crRNA) and trans-activating CRISPR RNA (tracrRNA), and a set of CRISPR-associated (cas) genes…
Glioma Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PM …
"Glioma Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Glioma Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the…
Vascular Access Devices Market is expected to Surge at a Significant CAGR of 6.6 …
Global Vascular Access Devices Market was valued at USD 4.59 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 6.75 billion by 2027. The demand for Vascular Access Devices is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like the rise…
Adult Growth Hormone Deficiency Market Size, Epidemiology, Pipeline, Therapies, …
Adult Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the pituitary gland in brain does not produce enough growth hormone. Most cases of Adult Growth Hormone Deficiency (AGHD) result from damage to the pituitary gland caused by a pituitary tumor or by treatment for this using surgery and/or radiotherapy. Adult Growth Hormone Deficiency (AGHD) is treated with growth hormone replacement therapy. The growth hormone that is used…
NSCLC Market Is Expected To Grow During The Forecast Period (2019-2032), DelveIn …
DelveInsight's "NSCLC Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the NSCLC, historical and forecasted epidemiology as well as the NSCLC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
NSCLC: An Overview
NSCLC is the most common type of lung cancer accounting for approximately 85% of all lung cancers. However, NSCLC metastasizes to other organs slower in comparison to SCLC,…
Endoscopic Ultrasound Market Size, Drivers, Barriers, Landscape | Key Players- B …
DelveInsight's Endoscopic Ultrasound Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of Endoscopic Ultrasound and the historical and forecasted Endoscopic Ultrasound market trends, globally, which comprises North America, Europe, APAC, and RoW.
The Endoscopic Ultrasound market report provides an overview of Endoscopic Ultrasound, applications of Endoscopic Ultrasound as well as its advantages and limitations. Additionally, the report provides insight on the Endoscopic Ultrasound market share by…
Go To Page: 1
